Skip to content
  • Bioequivalence
  • Community
  • Investors

Now providing Mesenchymal cell-based immunomodulation for Covid19-induced hypercytokinemia. Call us to learn more

Somata
Genesis Biopharmaceuticals
  • Covid-19
    • Clinical Trials
    • Products
      • Ventilator
  • Treatments
    • Neurodegenerative Diseases
      • Multiple sclerosis
      • Amyotrophic lateral sclerosis
      • Parkinson’s disease
      • Cerebral palsy
      • Autism
    • Diabetes T2
    • Critical limb ischemia
    • Kidney disorder
    • Stroke
  • Biopharmaceuticals
    • Neutrojen
    • Somajen
    • Stem cells
  • Services
    • Bioequivalence
    • Pharmacokinetics
  • Discoveries
    • Multiple Sclerosis
    • COVID-19

Category: Epithelial

Human Vaginal Epithelial Cells
Epithelial

Human Vaginal Epithelial Cells

by Mansi Dua
- Nov. 07, 2017
chat_bubble_outline0
Read morearrow_forward
Endometrial (Uterine) Epithelial Cells
Epithelial

Endometrial (Uterine) Epithelial Cells

by Mansi Dua
- Nov. 07, 2017
chat_bubble_outline0
Read morearrow_forward
Normal Human Small Airway Epithelial Cells, Primary
Epithelial

Normal Human Small Airway Epithelial Cells, Primary

by Mansi Dua
- Nov. 07, 2017
chat_bubble_outline0
Read morearrow_forward
Human Bronchial/Tracheal Epithelial Cells, Primary
Epithelial

Human Bronchial/Tracheal Epithelial Cells, Primary

by Mansi Dua
- Nov. 07, 2017
chat_bubble_outline0
Read morearrow_forward
Human Lobar Bronchial Epithelial Cells, Secondary
Epithelial

Human Lobar Bronchial Epithelial Cells, Secondary

by Mansi Dua
- Nov. 07, 2017
chat_bubble_outline0
Read morearrow_forward

Posts navigation

1 2 … 4 Next
https://www.facebook.com/somatagenesis
PO Box 66 Albion ID 83311, USA
International +91 992 149 6595
USA +1 646 583 1660
info@somatagenesis.com
  • Neutrojen
  • Somajen
  • Stem cells
  • Bioequivalence
  • Contact
  • COVID-19
  • Multiple Sclerosis Research
Copyright © 2025 Somata Genesis, Inc. | 416, Burlington Tower, Business Bay, Dubai, United Arab Emirates
  • Facebook
  • LinkedIn
  • Twitter